Ayurvedic-allopathic drug combo potent for diabetes: AIIMS


New Delhi [India]Jan 30 (ANI): The combination of the formulation ‘BGR-34’ and the allopathic drug ‘Glibenclamide’ has the potential to control blood sugar levels in patients with diabetes, according to a new study by doctors at All India Institute of Medical Sciences (AIIMS).

The results of the study not only improve the overall quality of life for diabetics, but also help to reduce the risk of a heart attack.

The study was conducted on animals over a period of 18 months during which doctors provided the Ayurvedic formulation ‘BGR-34’ and the allopathic drug glibenclamide separately to one group, while both drugs were combined to another group.

The experiment was carried out by Dr. Sudhir Chandra Sarangi, headed by the Pharmacology Department of AIIMS.

The study found that faster growth of diabetes can be disrupted when the allopathic drug is incorporated into BGR-34, an herbal formulation that acts as an antioxidant. BGR-34 does not make bad cholesterol grow in the body.

“The result of the experimental model shows that although the drugs of both pathies are effective in controlling the biochemical parameters during the treatment of diabetes to some extent, a combination of the two benefits patients only if they restore these biomarker parameters better than they do the individual effect of one and closer to the value in normal subjects, “the report said.

A doctor who was involved in the research said the results of the study were encouraging.

It was found that the combination group given Ayurvedic BGR-34 and glibenclamide had greater improvement in insulin levels than those given only an allopathic drug. It also showed the cholesterol-lowering (cardio-protective) effects for almost 40 to 28 days, “the doctor said.

A combination of herbs like Vijaysar, Daruharidra, Manjisth, Gudmar, Giloe and Methika from the upper region of the Himalayas, BGR-34, was discovered after intensive research by the two laboratories of the Council of Scientific and Industrial Research (CSIR) in Lucknow – Central Institute – Made from Medicinal and Aromatic Plants (CIMAP) and National Botanical Research Institute (NBRI).

Recently, a team of scientists from the University of Tehran also concluded in their separate study that herbal medicines with antioxidant properties can reduce the risk of Covid-19 in diabetics. (ANI)